Search

Yishan X Li

from Rancho Santa Fe, CA
Age ~60
Get Report
Also known as:
Yishan L Cui, Li Yishan, Yu Liu, Yi Shanli
Related to:
Hsiaowei Liu, 51Chungpin H Chen, 67Tony Li, 54Richard N Qiu, 62Liu Yuwei, 52Kimberly Liu, 28Jingrong J Cui, 62Catherine Z Li, 30Yue Jiang, 68Tiffany S LiuMichael SunWen Zheng, 62Tsueimei Lin, 63Jacqueline Z Li, 27Guowei Li, 59Jianping Liu, 62X I LiMike SunLi Jinlong, 61Aiqing Luo, 54Wei Lin, 50
Connected to:
Adeline Li, 33Agatha K Li, 48Aiping Li, 33Aiyi Li, 36Andi Li, 34Andre N Li, 27Anyun Li, 34Banny Li, 51Baozhen Li, 67Beatrice O Li, 68

Yishan Li Phones & Addresses

  • Rancho Santa Fe, CA
  • Pasadena, CA
  • San Diego, CA
  • Columbus, OH
  • 808 Arcturus Cir, San Mateo, CA 94404
  • Foster City, CA
  • San Francisco, CA
  • Albany, CA

Resumes

Resumes

Yishan Li Photo 1

Managing Partner

View page
Location:
13718 Treviso Ct, San Diego, CA 92130
Industry:
Biotechnology
Work:
Blossom Hill Ventures
Managing Partner
Tp Therapeutics Oct 2018 - Apr 2019
Co-Founder and Director
Tp Therapeutics Oct 2013 - Sep 2018
Co-Founder, Chairman, and Chief Executive Officer
Gb Healthwatch Oct 2012 - Apr 2018
Director, Board of Directors
Epitomics - An Abcam Company Dec 2003 - Apr 2013
Executive Vice President
Education:
University of California, Berkeley 1999 - 2001
Master of Business Administration, Masters University of California, Berkeley 1994 - 1997
The Ohio State University 1989 - 1994
Doctorates, Doctor of Philosophy, Biochemistry University of Science and Technology of China 1982 - 1987
Bachelors, Bachelor of Science, Chemistry
Skills:
Venture Capital
Venture Financing
Biotechnology
Lifesciences
Molecular Biology
Drug Discovery
Commercialization
Biochemistry
Technology Transfer
Protein Chemistry
Genomics
Medical Devices
Cell Biology
Drug Development
Genetics
Immunology
Biopharmaceuticals
Biomarkers
Start Ups
Pcr
Cell
Chemistry
Cancer
Cell Culture
Antibodies
Hplc
R&D
Gmp
Monoclonal Antibodies
Assay Development
Life Sciences
Entrepreneurship
Executive Management
Clinical Trials
Corporate Finance
Board of Directors
Sales and Marketing
Oncology
Small Molecules
Ipo
Strategic Planning
Business Strategy
Business Development
Languages:
English
Mandarin
Yishan Li Photo 2

Yishan Li

View page

Business Records

Name / Title
Company / Classification
Phones & Addresses
Yishan Li
President
Tp Therapeutics, Inc
Mfg Pharmaceutical Preparations
6150 Lusk Blvd, San Diego, CA 92121
6650 Lusk Blvd, San Diego, CA 92121
Yishan Li
Vice-President
Kenson Ventures
Biotechnology · Investor
695 Oak Grv Ave, Menlo Park, CA 94025
PO Box 969, Menlo Park, CA 94026

Publications

Isbn (Books And Publications)

The Aluria Chronicles: Yaoi

View page
Author

Yishan Li

ISBN #

1933664002

Us Patents

Diaryl Macrocycles As Modulators Of Protein Kinases

View page
US Patent:
20200216465, Jul 9, 2020
Filed:
Feb 21, 2020
Appl. No.:
16/797866
Inventors:
- San Diego CA, US
Yishan Li - San Diego CA, US
Evan W. Rogers - San Diego CA, US
Dayong Zhai - San Diego CA, US
International Classification:
C07D 498/18
Abstract:
The present invention relates to certain diaryl macrocyclic compounds, pharmaceutical compositions containing them, and methods of using them, including methods for treating cancer, pain, neurological diseases, autoimmune diseases, and inflammation.

Chiral Diaryl Macrocycles As Modulators Of Protein Kinases

View page
US Patent:
20190284209, Sep 19, 2019
Filed:
May 29, 2019
Appl. No.:
16/425407
Inventors:
- San Diego CA, US
Yishan LI - San Diego CA, US
Evan W. ROGERS - San Diego CA, US
Dayong ZHAI - San Diego CA, US
Wei DENG - San Diego CA, US
Jane UNG - San Diego CA, US
International Classification:
C07D 498/22
C07D 498/14
Abstract:
The present disclosure relates to certain chiral diaryl macrocyclic derivatives, pharmaceutical compositions containing them, and methods of using them to treat cancer, pain, neurological diseases, autoimmune diseases, and inflammation.

Diaryl Macrocycles As Modulators Of Protein Kinases

View page
US Patent:
20190169207, Jun 6, 2019
Filed:
Nov 29, 2018
Appl. No.:
16/204566
Inventors:
- San Diego CA, US
Yishan Li - San Diego CA, US
Evan W. Rogers - San Diego CA, US
Dayong Zhai - San Diego CA, US
International Classification:
C07D 498/18
Abstract:
The present invention relates to certain diaryl inacrocyclic compounds, pharmaceutical compositions containing them, and methods of using them, including methods for treating cancer, pain, neurological diseases, autoimmune diseases, and inflammation.

Macrocycle Kinase Inhibitors

View page
US Patent:
20190169208, Jun 6, 2019
Filed:
Jul 27, 2017
Appl. No.:
16/320589
Inventors:
- San Diego CA, US
Yishan LI - San Diego CA, US
Evan W. ROGERS - San Diego CA, US
Dayong ZHAI - San Diego CA, US
Jane UNG - San Diego CA, US
International Classification:
C07D 498/18
Abstract:
The present disclosure relates to certain macrocyclic kinase inhibitors, pharmaceutical compositions containing the same, and methods of using the same to treat disease.

Chiral Diaryl Macrocycles And Uses Thereof

View page
US Patent:
20180325901, Nov 15, 2018
Filed:
Jul 20, 2016
Appl. No.:
15/745915
Inventors:
- San Diego CA, US
Yishan LI - San Diego CA, US
Evan W. ROGERS - San Diego CA, US
Dayong ZHAI - San Diego CA, US
Wei DENG - San Diego CA, US
Zhongdong HUANG - San Diego CA, US
International Classification:
A61K 31/519
A61P 35/00
Abstract:
This disclosure relates to the use of certain diaryl macrocycle compounds, specifically (7S13R)-11-fluoro-7,13-di-methyl-6,7,13,14-tetrahydro-1,15-ethenopyrazolo [4,3-f][1,4,8,10]benzoxatriazacyclotridecin-4(5H)-one in the treatment of disease in mammals. This disclosure also relates to compositions including such compounds, and to methods of using such compositions in the treatment of diseases in mammals, especially in humans.

Chiral Diaryl Macrocycles As Modulators Of Protein Kinases

View page
US Patent:
20180186813, Jul 5, 2018
Filed:
Jun 30, 2016
Appl. No.:
15/740462
Inventors:
- San Diego CA, US
Yishan LI - San Diego CA, US
Evan W. ROGERS - San Diego CA, US
Dayong ZHAI - San Diego CA, US
Wei DENG - San Diego CA, US
Jane UNG - San Diego CA, US
International Classification:
C07D 498/22
C07D 498/14
Abstract:
The present disclosure relates to certain chiral diaryl macrocyclic derivatives, pharmaceutical compositions containing them, and methods of using them to treat cancer, pain, neurological diseases, autoimmune diseases, and inflammation.

Diaryl Macrocycles As Modulators Of Protein Kinases

View page
US Patent:
20170334929, Nov 23, 2017
Filed:
May 31, 2017
Appl. No.:
15/609962
Inventors:
- San Diego CA, US
Yishan LI - San Diego CA, US
Evan W. ROGERS - San Diego CA, US
Dayong ZHAI - San Diego CA, US
International Classification:
C07D 498/18
Abstract:
The present invention relates to certain diaryl macrocyclic compounds, pharmaceutical compositions containing them, and methods of using them, including methods for treating cancer, pain, neurological diseases, autoimmune diseases, and inflammation.

Diaryl Macrocycles As Modulators Of Protein Kinases

View page
US Patent:
20170002023, Jan 5, 2017
Filed:
Jan 23, 2015
Appl. No.:
15/113583
Inventors:
- San Diego CA, US
Yishan LI - San Diego CA, US
Evan W. ROGERS - San Diego CA, US
Dayong ZHAI - San Diego CA, US
Assignee:
TP Therapeutics, Inc. - San Diego CA
International Classification:
C07D 498/18
Abstract:
The present invention relates to certain diaryl macrocyclic compounds, pharmaceutical compositions containing them, and methods of using them, including methods for treating cancer, pain, neurological diseases, autoimmune diseases, and inflammation.
Control profile
Yishan X Li from Rancho Santa Fe, CA, age ~60 Get Report